CVE-2024-35429

Exploitation

Public exploit code exists. CISA's assessment records a public proof of concept. That is not a report of exploitation in the wild.

SSVC decision

• ExploitationpocPublic proof-of-concept exploit code exists. Not a report of exploitation in the wild.
• AutomatablenoAt least one step from reconnaissance to exploitation cannot be reliably automated.
• Technical ImpactpartialSuccessful exploitation gives limited control of the vulnerable component.

CISA publishes the decision points, not a final SSVC decision. The decision also depends on mission and well-being impact, which is a property of your deployment rather than of the vulnerability.

EPSS probability

0.95% probability of exploitation activity in the next 30 days.

EPSS percentile

Ranks above 58.7% of scored records. A rank, not a probability.

NVD base score

6.5 (CVSS v3.x), scored by the NVD independently of the CNA.

NVD CVSS vector

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N

NVD analysis status

Modified. NVD last modified this record on 2026-06-17.

Red Hat severity

No Red Hat rating. Red Hat rates the CVEs that affect its products.

Exploit-prediction scores from FIRST. Independent scoring and analysis status from the NVD. Vendor severity from Red Hat. Exploitation assessment and catalog membership from CISA.

Published

2024-05-30 16:20Z2 YR AGO

Last updated

2025-02-13 15:58Z1 YR AGO

Reserved

2024-05-17

Assigning CNA

mitre

Record state

PUBLISHED

Severity

Medium (CVSS 6.5)

CNA CVSS vector

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N

Weaknesses

• CWE-31Path Traversal: 'dir\..\..\filename'Variant
• CWE-22Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')Base

Data version

5.1

Document digest

72ebaa0c5ced77f9f65cba4512512956fec62083f26954a56d8efa705f7ce215

• github.comhttps://github.com/mrojz/ZKT-Bio-CVSecurity/blob/main/CVE-2024-35429.md